Trials
Search / Trial NCT05657665

Skin Tone Measurement Method Investigation for Pulse Oximetry

Launched by PHILIPS ELECTRONICS NEDERLAND B.V. ACTING THROUGH PHILIPS CTO ORGANIZATION · Dec 12, 2022

Trial Information

Current as of February 05, 2025

Completed

Keywords

Skin Types Pulse Oximetry

ClinConnect Summary

Skin tone bias in pulse-oximetry (SpO2) needs to be addressed urgently. While skin pigmentation is a prime candidate for the root cause of skin tone bias in SpO2, more research is needed. F A solid comparison and recommendation requires evaluation of several additional aspects that affect accuracy, precision, and reproducibility of the PMMs.

Briefly, these additional aspects that are evaluated in this study are listed below:

* operator bias
* impact of operator color blindness
* probe pressure
* probe aperture size
* device stability
* impact of blood on pigmentation measurement
* feasibi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adults (18-65 years)
  • 2. Fluent in either English or Dutch
  • 3. Participants who are willing and able to provide informed consent themselves.
  • 4. People with Von Luschan scores \<18 ('light skin' group) or \> 25 ('dark skin' group).
  • Exclusion Criteria:
  • 1. Skin conditions that could potentially interfere with the measurements:
  • piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
  • vascular or pigmentary or renal psoriasis
  • epidermal bullosum
  • other diseases that affect the skin (tone) of the body
  • 2. COVID-19 exclusion criteria\*:
  • Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
  • Having been positively tested as infected with COVID-19 in the past 14 days
  • Travelled to or from high risk COVID-19 areas in the past 14 days
  • Been in contact with a (suspected) COVID-infected person in the past 14 days
  • 3. Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
  • 4. Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
  • 5. Known allergic reaction to facial make-up
  • 6. Usage of tanning sprays/cremes
  • 7. Wearing make-up during the study visits (mascara is allowed)
  • No testing will be performed in the study. Participants will be asked if they have been positively tested.

About Philips Electronics Nederland B.V. Acting Through Philips Cto Organization

Philips Electronics Nederland B.V., operating through its Chief Technology Office (CTO) organization, is a leading global healthcare technology company focused on improving patient outcomes and enhancing the healthcare experience. With a commitment to innovation and excellence, Philips leverages advanced technologies and data-driven insights to develop and conduct clinical trials that explore new solutions in medical devices, imaging, and connected health. The organization prioritizes collaboration with healthcare professionals and regulatory bodies to ensure the safety, efficacy, and accessibility of its products, ultimately aiming to drive advancements in health and well-being worldwide.

Locations

Eindhoven, , Netherlands

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials